Mutation rate of p53 is about 12-28% among ER+HER2-/luminal breast cancer, while is nearly 80% in the Triple-Negative breast cancers (TNBC), which is the most aggressive subtype of breast cancer [12]. This evidence concerns the gene ERBB2 and breast carcinoma.